The suppressive role of SOX7 in hepatocarcinogenesis

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Wang, Chong ^a   Guo, Yu ^b   Wang, Jing ^b   Min, Zhiqun ^c  

^a XIAMEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; MESSENGER RNA; MYC PROTEIN; TRANSCRIPTION FACTOR SOX7; PRIMER DNA; SOX7 PROTEIN, HUMAN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TRANSCRIPTION FACTOR SOX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VOLUME; CARCINOGENESIS; CFU COUNTING; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOGENESIS; CELL LINE, TUMOR; COLONY-FORMING UNITS ASSAY; DNA PRIMERS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER NEOPLASMS; SOXF TRANSCRIPTION FACTORS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84901207709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097433     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365: 1118-1127.
3. White BD, Chien AJ, Dawson DW (2012) Dysregulation of Wnt/beta-catenin signaling in gastrointestinal cancers. Gastroenterology 142: 219-232.
4. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
5. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, et al. (1998) Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58: 2524-2527. (Pubitemid 28275419)
6. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, et al. (1998) Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 95: 8847-8851. (Pubitemid 28350577)
7. Cui J, Zhou X, Liu Y, Tang Z, Romeih M (2003) Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes. J Gastroenterol Hepatol 18: 280-287. (Pubitemid 36519145)
8. Herencia C, Martinez-Moreno JM, Herrera C, Corrales F, Santiago-Mora R, et al. (2012) Nuclear translocation of beta-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype. PLoS One 7: e34656.
9. Harley VR, Lovell-Badge R, Goodfellow PN (1994) Definition of a consensus DNA binding site for SRY. Nucleic Acids Res 22: 1500-1501. (Pubitemid 24166854)
10. Takash W, Canizares J, Bonneaud N, Poulat F, Mattei MG, et al. (2001) SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res 29: 4274-4283. (Pubitemid 33064768)
11. Stovall DB, Cao P, Sui G (2014) SOX7: From a developmental regulator to an emerging tumor suppressor. Histol Histopathol 29: 439-445.
12. Katoh M (2002) Expression of human SOX7 in normal tissues and tumors. Int J Mol Med 9: 363-368.
13. Zhang Y, Huang S, Dong W, Li L, Feng Y, et al. (2009) SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett 277: 29-37.
14. Zhong WD, Qin GQ, Dai QS, Han ZD, Chen SM, et al. (2012) SOXs in human prostate cancer: implication as progression and prognosis factors. BMC Cancer 12: 248.
15. Hayano T, Garg M, Yin D, Sudo M, Kawamata N, et al. (2013) SOX7 is down-regulated in lung cancer. J Exp Clin Cancer Res 32: 17.
16. Stovall DB, Wan M, Miller LD, Cao P, Maglic D, et al. (2013) The regulation of SOX7 and its tumor suppressive role in breast cancer. Am J Pathol 183: 1645-1653.
17. Ye X, Guo Y, Zhang Q, Chen W, Hua X, et al. (2013) betaKlotho suppresses tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3beta/cyclin D1 signaling pathway. PLoS One 8: e55615.
18. Pineau P, Nagai H, Prigent S, Wei Y, Gyapay G, et al. (1999) Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma. Oncogene 18: 3127-3134. (Pubitemid 29261233)
19. Emi M, Fujiwara Y, Ohata H, Tsuda H, Hirohashi S, et al. (1993) Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosomes Cancer 7: 152-157. (Pubitemid 23194424)
20. Wu GG, Li WH, He WG, Jiang N, Zhang GX, et al. (2014) Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma. PLoS One 9: e88796.
21. Shiraha H, Yamamoto K, Namba M (2013) Human hepatocyte carcinogenesis (review). Int J Oncol 42: 1133-1138.
22. Zimonjic DB, Popescu NC (2012) Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review). Int J Oncol 41: 393-406.